Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and/or female patients (females will be women of non-childbearing potential) with an historical diagnosis of type 2 diabetes mellitus, who are currently being treated with metformin at a dose at or near maximum.
Hb A1c between 7-10%.
Fasting C-peptide \>0.4 nmol/L.
You may not be if
History of clinically significant chronic conditions other than T2DM not well controlled by either diet or medications.
Patients with pancreatitis or considered a high risk for pancreatitis.
History of contraindications to metformin therapy.
Previous treatment with an approved or investigational GLP 1 mimetic.
Clareo Health | A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics
